Latest news with #Obagi
Yahoo
7 days ago
- Business
- Yahoo
Obagi, Milk Makeup Owner Waldencast Enters Filler Market With New Acquisition
Obagi injectables are in the works. Waldencast, the parent company of Milk Makeup and Obagi Medical skin care, has acquired Novaestiq Corp., an aesthetic and medical dermatological innovations company, as well as the U.S. rights to the Saypha line of hyaluronic acid injectable gels. Terms of the deal were not disclosed. More from WWD Polite Society Achieves in Two Years What Took Too Faced a Decade Ariana Grande's R.e.m. Beauty Hires CEO Lux Pascal, Vanessa Kirby and Xochitl Gomez Lead '60s-inspired Beauty Trend at 'The Fantastic Four: First Steps' Premiere The acquisition will sit under the Obagi brand, which will expand its offerings beyond skin care into the U.S. dermal filler market. 'We are excited to further diversify Obagi Medical's portfolio of medical-grade skin care with consumer centric, in-office injectable procedures,' said Michel Brousset, cofounder and chief executive officer of Waldencast. 'Adding proven products into our portfolio increases our addressable market and allows us to deliver solutions for professionals and patients seeking both skin care and aesthetic treatments, all under the trusted Obagi Medical brand.' Saypha, a product of Croma-Pharma GmbH, is developed and manufactured in Austria and marketed in more than 80 countries, but not yet available in the U.S. It is currently undergoing U.S. Food and Drug Administration approval. According to Waldencast, Saypha's proprietary technology delivers advanced HA treatments through a stable 3D matrix designed to provide natural-looking results with optimally balanced gel characteristics. 'We believe that great results start with great skin care and are perfected with great after care,' said Dr. Suzan Obagi, chief medical director at Obagi Medical. 'By combining Obagi Medical skin care with injectable procedures under the guidance of a qualified professional, patients can achieve more significant, longer-lasting and natural-looking results. This acquisition also allows our professionals to offer patients more personalized, higher quality and safer products that their customers are looking for.' On putting it under the Obagi brand as opposed to running it as a standalone entity, Brousset said: 'The Obagi brand is actually a big part of what is going to boost the performance of this business. Our vision is to create Obagi as a mega brand in the world of beauty aesthetics, and have Obagi as the big platform to market [aesthetics] through the trust that physicians have on Obagi and through the trust that consumers have on our existing infrastructure system business model.' Brousset is open to more M&A opportunities, especially in the aesthetics space. 'This is our first step into aesthetics. We expect to have more steps in the future.' Best of WWD Sesame Oil Skin Care: The Secret to Hydrated Skin or a Recipe for Clogged Pores? How Grooming Is Introducing Men to Self-care and Redefining Masculinity Clean Beauty Brand Ignae Makes Big U.S. Push With a New Look Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
The Independent
12-06-2025
- Health
- The Independent
A dermatologist says this medical-grade eye cream makes dark circles ‘noticeably brighter'
Under-eye dark circles can be caused by a variety of lifestyle factors, including tiredness, smoking and sun exposure. And with social media trends now encouraging us to ditch the concealer, you may find them even more of a nuisance. The good news? There might be an easy solution. According to Dr Ahmed El Muntasar – aka Mayfair's aesthetics doctor – minimising dark circles is easier than you think. By applying a medical-grade skincare product around your lower lash line, you can remedy the issue. Enter, Obagi's nu-derm fx cream (£81, a brightening, antioxidant-rich treatment that works to reduce skin pigment with repeated use. If you don't mind the high price tag, that is. If you're not familiar with Obagi, it's a US brand you'll often see stocked in professional skincare clinics. Its products are grounded in clinical research and it recently won 'skincare range of the year' at the Aesthetics Awards. Talking on the benefits of Obaji's nu-derm FX cream, Dr Muntasar told The Independent that it 'works by inhibiting tyrosinase – the enzyme responsible for melanin production. This helps reduce pigmentation and leaves the skin looking noticeably brighter and more even.' It does this with the help of an ingredient called arbutin, which he describes as 'incredibly effective'. Of course, when it comes to dark circles, Dr Muntasar admits that 'choosing the right treatment really depends on identifying the underlying issue whether it's vascular, skin laxity, volume loss (hollowness), or pigmentation.' But, for all intents and purposes, he advises that many of his patients suffer with at least 'some degree of pigmentation in the under-eye area' – the arginine in Obaji's nu-derm treatment will prove largely helpful. Aside from this seemingly magic component, the cream features vitamin C (ascorbic acid), vitamin E (tocopheryl acetate), exfoliating lactic acid and glycerin to attract moisture from the air. Together, these ingredients aim to soothe, hydrate, exfoliate and brighten, creating an all-round radiance-boosting effect. Consider us on board.
Yahoo
22-04-2025
- Business
- Yahoo
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Obagi Medical ("Obagi"), the fastest-growing professional skincare brand in the U.S. in 2024* and a subsidiary of Waldencast plc, (NASDAQ: WALD) ('Waldencast'), proudly introduces its latest breakthrough: Retinol + PHA Refining Night Cream. This advanced formulation is engineered to optimize skin renewal by leveraging the efficacy of Entrapped Retinol with the scientifically proven gentle exfoliating properties of Polyhydroxy Acid (PHA) Gluconolactone. This synergistic combination enhances cell turnover while reinforcing the skin barrier, resulting in a visibly refined, smoother, and more even complexion. Expanding on Obagi's trusted retinol portfolio, this innovative formula incorporates PHA—a next-generation exfoliant with a larger molecular structure than Alpha Hydroxy Acids (AHAs) and Beta Hydroxy Acids (BHAs). This distinction allows for effective resurfacing with minimal irritation, making it ideal for individuals seeking to improve skin texture and tone while maintaining hydration and skin barrier integrity. Additionally, the formula features Entrapped Retinol, a slow-release delivery technology that gradually delivers retinol into multiple layers of the skin over time. This controlled release helps maximize efficacy while minimizing the irritation commonly associated with vitamin A products. The result is an effective yet gentle introduction to retinol, suitable for beginners and those with sensitive skin who may struggle with stronger retinoids. 'Patient compliance is the key to achieving visible results. By using a slow-release, encapsulated retinol combined with a gentle exfoliating and hydrating PHA, this formula makes it easier for patients to tolerate nightly use,' said Dr. Suzan Obagi, Chief Medical Director at Obagi. 'As a result, they may experience improved skin texture and a noticeable reduction in blemishes.' Retinol + PHA Refining Night Cream is fortified with eight additional dermatologically recognized ingredients to support hydration, minimize irritation, and enhance skin resilience. These ingredients include: Sodium Hyaluronate – A potent humectant that deeply hydrates and retains moisture. Vitamin E (Tocopherol) – A powerful antioxidant that shields against oxidative stress while nourishing the skin. Squalane – A bio-compatible lipid that enhances hydration, reinforces the skin barrier, and improves texture. Glycerin – A clinically proven hydrating agent that maintains moisture balance and supports skin resilience. A four-week clinical study demonstrated the efficacy of Retinol + PHA Refining Night Cream, with participants experiencing significant improvements in skin texture and tone, including: 29% increase in skin smoothness* 10% improvement in skin tone evenness* 90% of users reporting visibly smoother skin texture* 90% observing a reduction in the appearance of blemishes* 'At Obagi, our mission is to transform skin. We wanted to create a retinol solution that delivers real results while being accessible to those with sensitive skin, blemish concerns, or who aren't ready for higher-strength retinoids," said Justin Giouzepis, Chief Marketing Officer of Obagi. "This formula was designed with both professionals and their patients in mind—addressing unmet needs with a gentle yet effective approach. We're thrilled to report that our clinical data found that in just eight weeks, there was a 2.3x increase in the number of participants who felt comfortable in their own skin.' The Retinol + PHA Refining Night Cream, priced at $135 is now available through partnering professional channels. They will be available for customers to purchase on on 5.5.2025. *Results based on a 2024-2025 8-week clinical test. Data on file at Obagi Cosmeceuticals LLC. About Obagi Medical Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, with a legacy of 35+ years of experience. Initially known for its leadership in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi products are designed to address a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne, and sun damage. As the fastest-growing professional skincare brand in the U.S. in 2024,* Obagi empowers individuals to achieve healthy, beautiful skin. The brand continues to lead in physician-recommended skincare solutions and is recognized as the #1 Physician-Recommended Brand for At-Home Skincare Products for Hyperpigmentation, Fine Lines & Wrinkles, and Sagging Skin & Loss of Elasticity.** More information about Obagi is available on the brand's website, *Among the Top 10 Professional Skin Care Brands in the U.S., According to Kline's 2024 Global Professional Skin Care Series (China, Europe and the U.S.) **According to Kline's Physician- Dispensed Skin Care: U.S. Perception and Satisfaction Survey 2023. About WaldencastFounded by Michel Brousset and Hind Sebti, Waldencast's ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast's vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand's distinct DNA. The first step in realizing its vision was the business combination with Obagi Cosmeceuticals and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset-light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: Media Contact:obagi@ A photo accompanying this announcement is available at in to access your portfolio
Yahoo
22-03-2025
- Business
- Yahoo
Waldencast Full Year 2024 Earnings: EPS Misses Expectations
Revenue: US$273.9m (up 26% from FY 2023). Net loss: US$42.4m (loss narrowed by 53% from FY 2023). US$0.38 loss per share (improved from US$0.89 loss in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 95%. The primary driver behind last 12 months revenue was the Obagi segment contributing a total revenue of US$149.3m (55% of total revenue). The largest operating expense was General & Administrative costs, amounting to US$201.8m (82% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of US$11.1m. Explore how WALD's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 3.5% growth forecast for the Personal Products industry in the US. Performance of the American Personal Products industry. The company's shares are down 3.1% from a week ago. What about risks? Every company has them, and we've spotted 1 warning sign for Waldencast you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
10-02-2025
- Health
- Yahoo
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection
New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant ComplexionNEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Obagi Medical ('Obagi'), a leader in advanced skincare innovation and the originator of medical-grade skincare, proudly unveils the latest groundbreaking additions to its highly regarded SUZANOBAGIMD® collection. The new products - Super Antioxidant Serum and Moisture Restore Hydration Replenishing Cream - offer cutting-edge solutions to address common skincare concerns such as skin discoloration and brightening, oxidative stress, and skin hydration to maintain a healthy skin barrier function. Formulated to be safe and effective for all skin types—whether sensitive, oily, dry, or somewhere in between—Obagi's inclusive approach ensures that everyone can experience the benefits of advanced skincare, no matter their unique needs or concerns. Developed by Dr. Suzan Obagi, a distinguished dermatologist and the Chief Medical Director at Obagi, the powerhouse duo of skincare solutions reflects her extensive research and expertise in dermatologic surgery and skin health. Her expertise in formulation is drawn from her extensive experience treating thousands of patients each year, addressing a wide range of concerns. The most common issues she observes are hyperpigmentation and challenges with sensitive skin. Dr. Obagi's groundbreaking work, especially in understanding the unique needs of skin of color and the needs of sensitive skin types, led her to identify the five key pathways essential for optimal skin health. These pathways include reducing pigment formation and visibly improving hyperpigmentation, calming redness and reducing skin irritation, combating oxidative stress, supporting cell turnover, and restoring the skin barrier. Dr. Obagi has created effective products that do not irritate the skin while delivering results you can see in as little as a few weeks in some cases. Dr. Suzan Obagi, Chief Medical Director at Obagi, commented, 'I am so excited to finally share these groundbreaking innovations with the world. These products are the culmination of years of research and patient testing, driven by my passion for helping patients unveil their naturally radiant skin without irritation. By incorporating cutting-edge ingredients like encapsulated silymarin to protect against oxidative stress and multi-weight hyaluronic acids for multi-layered hydration, we've developed solutions that truly push the envelope in skincare. I genuinely believe these novel formulations not only set a new standard but also reflect my unwavering commitment to treating skin holistically, ensuring health, resilience, and a luminous glow for every skin type.' Drawing on this wealth of expertise in treating skin discoloration, Dr. Obagi formulated these latest additions to her namesake collection to transform skin health and deliver a radiant, brighter complexion. The collection includes the new Super Antioxidant Serum, providing medical-grade defense against oxidative stress for more resilient, radiant and youthful-looking skin. Super Antioxidant Serum is formulated with a potent blend of antioxidants, including encapsulated Silymarin and stabilized Vitamin C, to neutralize free radicals, combat oxidative stress, and brighten skin. Moisture Restore Hydration Replenishing Cream is a medical-grade, multi-layered moisturizer which delivers intense, multi-layered hydration. With a blend of both low and high-molecular-weight Hyaluronic Acids this cream delivers moisture to different layers of the skin. Delivering both immediate and long-lasting results, these products were clinically tested by Dr. Obagi and third party clinical graders. During testing of Super Antioxidant Serum and Moisture Restore Hydration Replenishing Cream, 94% of subjects felt their skin was refreshed and smoother immediately after a single application* and 97% of subjects observed an improvement in overall skin appearance after 2 weeks* including: Visible improvement in the appearance of fine lines Visible improvement in the appearance of hyperpigmentation Visibly calms irritation and boosts hydration Justin Giouzepis, Chief Marketing Officer of Obagi, added, 'We're thrilled to partner with Dr. Suzan Obagi on bringing to market Super Antioxidant Serum and Moisture Restore, products designed to address the critical needs of both skin brightening and hydration. Obagi is the leader in innovating products that defend against environmental aggressors with our vitamin C collection and products that treat hyperpigmentation with the Obagi Nu-Derm® collection. Having Super Antioxidant Serum in the Obagi portfolio provides professionals with an additional oxidative stress fighting product to recommend to their patients who may have sensitive skin but don't want to compromise on results. We know achieving radiant, healthy skin shouldn't come at the cost of irritation, which is why we've prioritized gentle yet effective formulations suitable for even the most sensitive skin types. These launches represent our commitment to providing inclusive skincare solutions for everyone." The SUZANOBAGIMD® Super Antioxidant Serum, priced at $158, and the SUZANOBAGIMD® Moisture Restore Hydration Replenishing Cream, priced at $78, are now available through partnering professional channels. They will be available for customers to purchase on on 2.24.2025. *Results are based on a 2024 2-week clinical test, with subjects using SOMD Super Antioxidant Serum & Moisture Restore Replenishing Cream (if needed) daily within protocol. About Obagi MedicalObagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, refined with a legacy of 35 years' experience. First known as leaders in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. Backed by science and trusted by professionals, Obagi empowers individuals to achieve healthy, beautiful skin. More information about Obagi is available on the brand's website, About WaldencastFounded by Michel Brousset and Hind Sebti, Waldencast's ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast's vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand's distinct DNA. The first step in realizing its vision was the business combination with Obagi Cosmeceuticals and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset-light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: Media Contact:obagi@ A photo accompanying this announcement is available at in to access your portfolio
